Mycobacterium tuberculosis Hsp70 as a cancer vaccine adjuvant: Immunomodulatory mechanisms and tumor microenvironment remodeling. Liu P, Sang Z, Liu K, Zhang M, et al. Vaccine 2025;62:127493.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu P, Sang Z, Liu K, Zhang M, et al. Mycobacterium tuberculosis Hsp70 as a cancer vaccine adjuvant: Immunomodulatory mechanisms and tumor microenvironment remodeling. Vaccine 2025;62:127493.
PMID: 40652685